Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 13 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase I/II Chemotherapy with L-Alanosine for Refractory Pediatric Solid Tumors and Relapsed Pediatric Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				under 21				NCI				POG-8155


2.		Phase II Evaluation of L-Alanosine in Acute Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 16				NCI				SWOG-8051

Last Modified: 4/26/2007


3.		Phase II Chemotherapy with Single Agents Selected by Soft Agar Colony Sensitivity Studies for Advanced Renal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MAYO-805002 NCCTG-805002, NCI-W81-0587


4.		Phase II Chemotherapy with PALA/L-Alanosine for Residual, Recurrent, or Metastatic Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MAYO-814603


5.		Phase II Single-Agent Chemotherapy in Patients with Advanced Ovarian Carcinoma Using Agents Selected by Soft Agar Colony Sensitivity Studies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MAYO-816101

Last Modified: 4/26/2007


6.		Phase II Master Protocol for Chemotherapy for Recurrent or Stage IV Renal Cell Carcinoma --- VBL vs L-Alanosine vs Acivicin vs CTX vs Misonidazole vs Aminothiadiazole

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				EST-1882


7.		Phase II Chemotherapy with L-Alanosine for Patients with Metastatic Carcinoma of the Breast Refractory to Standard Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-8304

Last Modified: 12/6/2007


8.		Phase II Therapy with PALA/L-Alanosine and with Cimetidine as a Single Agent for Metastatic Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				NCCTG-837051 NCCTG-83-70-51


9.		Phase II Chemotherapy with L-Alanosine for Advanced Large Bowel Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MAYO-804601


10.		Phase II Chemotherapy with L-Alanosine for Advanced Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MAYO-807003

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute